Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial von Akhondzadeh, S., Sabet, M. Shafiee, Harirchian, M. H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S. Sh, Yousefi, M. H., Alimardani, R., Jamshidi, A., Zare, F., Moradi, A.

Volltext

Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study von Harirchian, M. H., Tekieh, A. H., Modabbernia, A., Aghamollaii, V., Tafakhori, A., Ghaffarpour, M., Sahraian, M. A., Naji, M., Yazdanbakhsh, M.

Volltext

Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia von Siroos, B, Harirchian, MH, Abolfazli, R

Volltext

Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS von Mohammadzadeh, M, Kolahi, S, Mehrabi Nejad, M-M, Firouznia, K, Naghibi, H, Mohammadzadeh, A, Shakiba, M, Mohebi, F, Komaki, H, Sharifian, H, Hashemi, H, Harirchian, M H, Azimi, A, Adin, M E, Yousem, D M

Volltext

Sympathetic skin response (SSR) in multiple sclerosis and clinically isolated syndrome: A case-control study von Aghamollaii, V, Harirchian, M.H, Modabbernia, A, Ghaffarpour, M, Mousavi, M, Tafakhori, A

Volltext

Lafora disease: a case report, pathologic and genetic study von Harirchian, M H, Shandiz, E Esmailee, Turnbull, J, Minassian, B A, Shahsiah, R

Volltext

Developing a Multi-channel Beamformer by Enhancing Spatially Constrained ICA for Recovery of Correlated EEG Sources von Samadzadehaghdam, Nasser, MakkiAbadi, Bahador, Eqlimi, Ehsan, Mohagheghian, Fahimeh, Khajehpoor, Hassan, Harirchian, Mohammad Hossein

Volltext

Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report von Harirchian, M.H, Taalimi, A, Siroos, B

Volltext

"THE RELATION OF HYPERHOMOCYSTEINEMIA TO COGNITIVE FUNCTION AND BRAIN ATROPHY IN PATIENTS WITH MULTIPLE SCLEROSIS " von M. Ghaffarpour, M. Maghbooli, M. H. Harirchian H. M. Ghabaie-Hashemi

Volltext

Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients von Zamani, M., Mehri, M., Kollaee, A., Yenki, P., Ghaffarpor, M., Harirchian, M.H., Shahbazi, M.

Volltext

"THE RELATION OF HYPERHOMOCYSTEINEMIA TO COGNITIVE FUNCTION AND BRAIN ATROPHY IN PATIENTS WITH MULTIPLE SCLEROSIS " von M. Ghaffarpour, M. Maghbooli, M. H. Harirchian H. M. Ghabaie-Hashemi

Volltext

Multiparametric qMTI Assessment and Monitoring of Normal Appearing White Matter and Classified T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis von Fooladi, M., Riyahi Alam, N., Sharini, H., Firouznia, K., Shakiba, M., Harirchian, M.H.

Volltext

STROKE IN YOUNG ADULTS: A RETROSPECTIVE STUDY OF 68 CASES von M. H. Harirchian, M. Ghaffarpour, D. Doratotaj M. B. Akhavirad

Volltext

Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis — Results of the BetaPlus observational cohort study von Pozzilli, Carlo, Schweikert, Bernd, Ecari, Ugo, Oentrich, Wolfgang

Volltext

PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS von M. Ghaffarpour, S. S. Hejazie, M. H. Harirchian, H. Pourmahmoodian

Volltext

Vestibular evoked myogenic potential in multiple sclerosis patients von Harirchian, M H, Karimi, N, Nafissi, S

Volltext

The relation between intracranial and intraocular pressures: Study of 50 patients von Sajjadi, Seyed A., Harirchian, Mohammad H., Sheikhbahaei, Nasim, Mohebbi, Mohammad R., Malekmadani, Mohammad H., Saberi, Hooshang

Volltext

Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease von Sayad, Azadeh, Noruzinia, Mehrdad, Zamani, Mahdi, Harirchian, Mohammad Hossein, Kazemnejad, Anoshirvan

Volltext

Cortical adaptation in patients with clinically isolated syndrome; perspectives for predicting multiple sclerosis von Harirchian, M H, Oghabian, MA, Rezvanizade, A R, Fakhri, M

Volltext

ORIGINAL ARTICLE: Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial: Saffron in the treatment of Al... von Akhondzadeh, S., Sabet, M. Shafiee, Harirchian, M. H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S. Sh, Yousefi, M. H., Alimardani, R., Jamshidi, A., Zare, F., Moradi, A.

Volltext